Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography (NCT07512830) | Clinical Trial Compass
RecruitingNot Applicable
Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography
France150 participantsStarted 2026-02-18
Plain-language summary
Transoesophageal echocardiography (TOE) is a routine cardiology examination that is performed in most cases under local anaesthesia and is recommended for many indications.The objective of our study will be to evaluate the expected beneficial effect of using conversational hypnosis and hypnosis during a transoesophageal ultrasound examination performed directly in the examination room by the cardiologist conducting the examination.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patient aged ≥ 18 years old
* Patient requiring a transoesophageal ultrasound scan under local anaesthetic.
* Patient affiliated to a health insurance scheme
* French-speaking patient
* Patient who has given their free, informed and express verbal consent
Exclusion Criteria:
Patient with a contraindication to transoesophageal ultrasound (significant radiation exposure to the chest, oesophageal pathology with risk of bleeding)
* Patients with known schizophrenia or known psychiatric illness (documented in medical records)
* Patients with known dementia or known cognitive impairment (documented in medical records)
* Patients already included in an interventional research protocol
* Patients under guardianship or curatorship
* Patients deprived of their liberty
* Patients under judicial protection
* Pregnant or breastfeeding patients
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
the degree of comfort felt during the procedure, measured on a visual analogue scale (VAS) (from 0 to 10) immediately after the examination